000 01748 a2200457 4500
005 20250513231022.0
264 0 _c20010405
008 200104s 0 0 eng d
022 _a1043-0342
024 7 _a10.1089/104303401450933
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan't Hof, W
245 0 0 _aManipulation of the cytoplasmic and transmembrane domains alters cell surface levels of the coxsackie-adenovirus receptor and changes the efficiency of adenovirus infection.
_h[electronic resource]
260 _bHuman gene therapy
_cJan 2001
300 _a25-34 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdenoviridae
_xphysiology
650 0 4 _aAdenoviridae Infections
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aCHO Cells
_xmetabolism
650 0 4 _aCOS Cells
650 0 4 _aCoxsackie and Adenovirus Receptor-Like Membrane Protein
650 0 4 _aCricetinae
650 0 4 _aDNA Primers
_xchemistry
650 0 4 _aEnterovirus
_xphysiology
650 0 4 _aFluorescent Dyes
650 0 4 _aGene Transfer Techniques
650 0 4 _aGenetic Vectors
650 0 4 _aGlycosylphosphatidylinositols
_xmetabolism
650 0 4 _aHumans
650 0 4 _aOligopeptides
650 0 4 _aPeptides
_xmetabolism
650 0 4 _aPhosphatidylinositol Diacylglycerol-Lyase
650 0 4 _aRNA, Messenger
_xanalysis
650 0 4 _aReceptors, Virus
_xmetabolism
650 0 4 _aType C Phospholipases
_xpharmacology
650 0 4 _abeta-Galactosidase
_xgenetics
700 1 _aCrystal, R G
773 0 _tHuman gene therapy
_gvol. 12
_gno. 1
_gp. 25-34
856 4 0 _uhttps://doi.org/10.1089/104303401450933
_zAvailable from publisher's website
999 _c11116040
_d11116040